Addyi Rises Again

July 11, 2018

Addyi, a drug that made a splash when it was approved in the summer of 2015 as the first “female Viagra,” is back. Its rise, fall, and rise again is an example of shrewd pharmaceutical marketing and the potential dangers it can have on patients

Quick Read

Depending on whom you ask, Addyi is the overdue answer to an unmet need or just another way to shame women

Quick Read

Oooh, it was going to be so good for women. It was going to bring back our flagging mojos en masse, save slumping relationships, and, if that weren’t enough, rectify what some were calling “persistent gender bias” at the FDA

Quick Read